Professor Paul Kaye from the University of York, whose research team was recently granted €8…
Category:
Pharma
-
-
ViiV’s investigational, long-acting injectable cabotegravir was found to be 66% more effective than daily pills…
-
On the heels of a carcinogen scare that drove the company to pull three lots…
-
While federal and state leaders wrangle with reopening of businesses, surges in new cases, resistance…
-
Introduction Understanding the pathophysiology of the COVID-19 pandemic is key to develop strategies for both…
-
Drug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug…
-
A single shot every two months prevents H.I.V. better than the most commonly used daily…
-
Regeneron Pharmaceuticals launches the Phase III trials of REGN-COV2 for treatment and prevention of COVID-19.…
-
Posted on July 7th, 2020 by Matthew Clark in Pharma R&D Scientists have long looked…
-
The UK’s medical research charities are calling for urgent financial support following decimation of research…